Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
3,942.00    -2.00 (-0.05%)
Bid:
3,938.00
Ask:
3,942.00
Spread: 4.00 (0.102%)
Market Cap: £14.89b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Director/PDMR Shareholding

30 Jun 2006 08:55

Halma PLC30 June 2006 HALMA p.l.c. DIRECTORS and PDMRs INCREASE SHAREHOLDINGS At a Meeting of the Share Plans Committee of the Board of Halma p.l.c. held on29 June 2006, a total of 414,730 additional ordinary shares in the Company wereallotted under the provisions of the Company's Share Option Schemes to Directorsand PDMRs of the Company, following the exercise of share options, as set outbelow. Following the execution of the net transactions noted below, the totalshareholdings of the Directors and PDMRs increased by 126,624 shares. Andrew Williams, Director 17,500 shares were allotted to Andrew Williams at an exercise price of 163.50pper share. In addition to the 17,500 shares allotted above, the Company has receivednotification that Andrew Williams purchased 18,480 shares in the Company at195.5p per share on 29 June 2006. After the above transactions, the beneficial holding of Andrew Williams in theordinary shares of Halma p.l.c. increases by 35,980 shares to 72,473 shares(0.02% of the issued ordinary share capital). Kevin Thompson, Director 99,932 shares were allotted to Kevin Thompson. The exercise prices were as follows: No of shares Price per share 15,466 138.01p 19,066 138.00p 65,400 122.50p To finance the exercise of these share options and the associated tax liability,Kevin Thompson sold 72,972 shares on 29 June 2006 at 194.625p per share. After the above transactions, the beneficial holding of Kevin Thompson,including family interests, in the ordinary shares of Halma p.l.c. increases by26,960 shares to 99,609 shares (0.027% of the issued ordinary share capital). Neil Quinn, Director 203,466 ordinary shares were allotted to Neil Quinn. The exercise prices were as follows: No of shares Price per share 19,066 138.00p 84,400 122.50p 100,000 116.50p To finance the exercise of these share options and the associated tax liability,Neil Quinn sold 184,400 shares on 29 June 2006 at 194.625p per share. After the above transactions, the beneficial holding of Neil Quinn in theordinary shares of Halma p.l.c. increases by 19,066 shares to 69,118 shares(0.019% of the issued ordinary share capital). Keith Roy, Director 43,066 shares were allotted to Keith Roy at an exercise price of 139.50p per share. To finance the exercise of these share options and the associated tax liability,Keith Roy sold 30,953 shares on 29 June 2006 at 194.625p per share. After the above transactions, the beneficial holding of Keith Roy, includingfamily interests, in the ordinary shares of Halma p.l.c. increases by 12,113shares to 760,649 shares (0.206% of the issued ordinary share capital). Nigel Young, PDMR 19,066 shares were allotted to Nigel Young at an exercise price of 138.00p pershare. To finance the exercise of these share options and the associated tax liability,Nigel Young sold 13,557 shares on 29 June 2006 at 194.625p per share. After the above transactions, the beneficial holding of Nigel Young, includingfamily interests, in the ordinary shares of Halma p.l.c. increases by 5,509shares to 34,932 shares (0.009% of the issued ordinary share capital). Adam Meyers, PDMR 20,000 shares were allotted to Adam Meyers at an exercise price of 122.50p pershare. Adam Meyers' existing beneficial interest in the ordinary shares of the Companyis held through the Halma Holdings Inc. Profit Sharing Savings Retirement Plan.Due to the unitised nature of the retirement plan and fluctuations in exchangerates, the precise number of ordinary shares in Halma p.l.c. in which AdamMeyers is interested may fluctuate. After the above transaction, the beneficialholding of Adam Meyers in the ordinary shares of Halma p.l.c. as at 29 June 2006increases by 20,000 shares to 24,367 shares (0.007% of the issued ordinary sharecapital). Carol Chesney, PDMR 11,700 shares were allotted to Carol Chesney at an exercise price of 163.50p pershare. To finance the exercise of these share options and the associated tax liability,Carol Chesney sold 4,704 shares on 29 June 2006 at 194.625p per share. After the above transactions, the beneficial holding of Carol Chesney in theordinary shares of Halma p.l.c. increases by 6,996 shares to 7,384 shares(0.002% of the issued ordinary share capital). Issued ordinary share capital Following the issue of ordinary shares as a result of the share optionsexercised on 29 June 2006, the issued ordinary share capital of the Company isincreased to 369,956,928 shares. Contact for further information: Andrew Williams Chief Executive, Halma p.l.c. Tel: +44 (0)1494 721111 A copy of this announcement, together with other information about Halma, may beviewed on its website: www.halma.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Apr 20227:00 amRNSAcquisition
7th Apr 20227:00 amRNSSite Visit
28th Mar 20221:59 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading update
21st Feb 20227:00 amRNSAcquisition
17th Jan 20227:00 amRNS2021 AGM – Voting Results Update Statement
30th Nov 20211:05 pmRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSAcquisition
18th Nov 20217:00 amRNSHalf Year Results
15th Nov 20217:00 amRNSDirectorate Change
15th Oct 20211:06 pmRNSDirector/PDMR Shareholding
4th Oct 20212:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20211:01 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading update
9th Sep 202110:22 amRNSDirector Declaration
9th Aug 20217:00 amRNSM&A Update
26th Jul 202111:01 amRNSDirector/PDMR Shareholding
22nd Jul 20213:00 pmRNSResult of AGM
5th Jul 20214:05 pmRNSDirector/PDMR Shareholding
30th Jun 20211:50 pmRNSDirector/PDMR Shareholding
23rd Jun 20214:47 pmRNSAnnual Financial Report
10th Jun 20217:01 amRNSUnaudited restated segmental information
10th Jun 20217:00 amRNSFull Year Results 2021
27th Apr 20217:00 amRNSAcquisition
26th Mar 20217:00 amRNSAppointment of independent non-executive Director
24th Mar 20217:00 amRNSTrading update
23rd Feb 20217:54 amRNSDirector Declaration
10th Feb 20214:52 pmRNSDirector/PDMR Shareholding
9th Feb 20217:00 amRNSDirectorate Change
21st Dec 20202:00 pmRNSAcquisition
18th Dec 20207:00 amRNSDisposal
4th Dec 20207:04 amRNSDirector Declaration
2nd Dec 20204:08 pmRNSDirector/PDMR Shareholding
25th Nov 20203:20 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSHALF YEAR RESULTS 2020/21
5th Oct 20201:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:05 amRNSDirector Declaration
23rd Sep 20207:00 amRNSChair retirement
23rd Sep 20207:00 amRNSTrading update
4th Sep 20204:57 pmRNSResult of AGM
31st Jul 20204:06 pmRNSDirector/PDMR Shareholding
24th Jul 20205:02 pmRNSAnnual Financial Report
17th Jul 20209:32 amRNSDirector/PDMR Shareholding
14th Jul 20207:00 amRNSFinal Results
15th May 20201:29 pmRNSElectronic Communications with Shareholders
27th Apr 202012:46 pmRNSDisclosure of Rights Attached to Equity Shares
21st Apr 20207:00 amRNSCOVID-19 Update
2nd Apr 20207:05 amRNSExecutive Board changes
19th Mar 20207:00 amRNSTrading Statement
5th Mar 20209:00 amRNSInvestor Event

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.